- Country: Lithuania
- Summary: New Medicinal Products Reimbursed from the Rare Diseases Fund (7925-1)
- LTT Ref No: 112263903
- Deadline: 27 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 790374-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- See in procurement documents.
Bexarotene
Birch (Betula pendula/pubescens) bark refined dry extract
Diazoxide
Entrektinib
Folic acid
Ravulizumab
Maralixibat chloride *
Migalastat *
Doc Title: New medicinal products reimbursed by the Rare Disease Fund (7925-1 )
Contract Type: - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNew Medicinal Products Reimbursed from the Rare Diseases Fund (7925-1) - Lithuania Tender
The VŠĮ VILNIUS UNIVERSITY HOSPITAL SANTARAS KLINIKOS (PV), a Government sector organization in Lithuania, has announced a new tender for New Medicinal Products Reimbursed from the Rare Diseases Fund (7925-1). This tender is published on LithuaniaTenders under LTT Ref No: 112263903 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-27.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
